Assessing TB Laboratory Capacity Before Introducing New Tests
Adding a tuberculosis test can expand diagnostic access, shorten referral times, and improve treatment decisions. It can also expose weaknesses in staffing, biosafety, specimen transport, equipment maintenance, result reporting, and quality control. A capacity assessment helps laboratory leaders determine whether a proposed assay can be introduced safely and consistently rather than assuming that purchasing an instrument creates operational readiness.
The assessment should examine the entire testing pathway, from the moment a specimen is requested to the point when a verified result reaches the clinician. It should combine document review, staff interviews, direct observation, workload analysis, and practical checks of equipment and facilities. The aim is to identify conditions that must be in place before implementation, as well as gaps that can be addressed during a phased rollout.
The GLI Quality Tool offers a useful structure for this work because its four-phase roadmap connects laboratory improvement to twelve Quality Systems Essentials. Using that framework keeps the assessment broader than a technology review and links test expansion to an established quality management system.
Define The Decision And Scope
Begin by describing the proposed test in operational terms. Specify the disease or drug-resistance question it will address, the expected testing volume, the specimen types involved, the required turnaround time, and the level of the laboratory that will perform it. A molecular assay for rapid detection of rifampicin resistance may have different infrastructure, biosafety, referral, and reporting requirements from a culture-based method or a new microscopy service.
Clarify whether the laboratory will introduce a new platform, add a new assay to existing equipment, or transfer testing from another site. Record the intended patient population and the facilities that will send specimens. This defines the likely demand and prevents an assessment based on an unrealistic pilot volume.
Set decision criteria before collecting evidence. For example, implementation may require trained staff on every shift, uninterrupted power, acceptable contamination control, external quality assessment enrollment, validated procedures, and a documented maintenance plan. Criteria should distinguish between conditions that are essential before launch and improvements that can be completed after limited implementation.
Map Demand And The Existing Workflow
Review current testing volumes, positivity rates, referral patterns, rejected specimens, stock-outs, turnaround times, and instrument downtime. Examine at least several recent months of data where possible, and account for seasonal changes or planned program expansion. Demand estimates should include repeat testing, invalid results, quality control runs, proficiency testing, and likely increases after the new service becomes available.
Map each step from patient identification through sample collection, labeling, packaging, transport, reception, processing, analysis, verification, reporting, and follow-up. Observe the process during routine work rather than relying solely on standard operating procedures. A test may appear feasible at the analytical stage while delays occur at reception, result authorization, or courier dispatch.
Specimen management deserves particular attention. Determine whether collection sites can provide the right containers, volumes, labels, request forms, and transport conditions. Review how staff handle unsuitable, leaking, unlabeled, delayed, or insufficient specimens. The guidance on specimen acceptance criteria can help laboratories create consistent decisions and communicate them to referring facilities.
Review Readiness Across Quality Systems
Assess personnel by comparing projected workload with actual staffing, competency, supervision, leave coverage, and turnover. A training certificate does not prove ongoing competence, so review competency assessments, error records, refresher training, and access to technical support. Include reception, biosafety, data management, equipment care, result authorization, and communication roles, not only testing staff.
Examine the facility and safety controls required by the method. Check workflow separation, ventilation, access control, personal protective equipment, decontamination, waste treatment, spill response, and exposure management. Confirm that safety procedures are visible, practiced, and supported by available supplies. If the new test changes specimen manipulation or creates additional aerosol risk, the existing risk assessment may need revision.
Review equipment and supplies through records rather than inventory counts alone. Check installation qualification, calibration or verification, preventive maintenance, service contracts, backup arrangements, temperature monitoring, reagent storage, lot acceptance, and stock management. Assess whether the laboratory can obtain consumables reliably and whether it has a contingency process for instrument failure or delayed shipments.
Documentation, assessment, and improvement systems should be assessed at the same time. Look for controlled procedures, worksheets, forms, amended reports, result review rules, internal quality control, nonconformity management, audits, and corrective action records. Laboratories can use the user instructions to navigate phase-specific checklists and connect findings to the relevant quality system elements.
Test Operational Capacity
A practical capacity review should test whether the laboratory can sustain the proposed service during ordinary pressure. Compare maximum instrument throughput with realistic daily capacity after breaks, cleaning, quality control, invalid runs, maintenance, and staff absences. Consider whether specimens arrive in batches that create bottlenecks, and whether reporting systems can handle the expected number of results.
The following matrix can organize evidence and highlight conditions that require action before launch:
| Capacity area | Evidence to review | Warning signs | Readiness question |
|---|---|---|---|
| Demand and workload | Recent volumes, referral forecasts, turnaround data | Unexplained peaks, unmeasured backlog, excessive repeat testing | Can the service handle routine and peak demand? |
| Personnel | Duty rosters, competency records, supervision plans | One trained operator, weak leave cover, overdue assessment | Are enough competent staff available at all times? |
| Specimens | Rejection logs, transport records, collection procedures | Frequent leakage, missing identifiers, long transport delays | Will acceptable specimens arrive in suitable condition? |
| Equipment and supplies | Maintenance logs, stock cards, service agreements | Reagent interruptions, unresolved faults, no backup plan | Can testing continue when equipment or supplies fail? |
| Safety and facilities | Risk assessments, incident reports, waste records | Poor segregation, inadequate PPE, unsafe workflow | Can staff and the environment be protected? |
| Quality and reporting | QC charts, EQA results, audits, LIS or registers | Unreviewed errors, delayed reports, incomplete traceability | Can results be verified, documented, and communicated? |
Use direct observation or a small simulation where feasible. Ask staff to receive a specimen, check acceptance criteria, prepare the work area, perform required quality control, record the run, review a result, and manage an invalid or rejected sample. This reveals practical barriers that a checklist may miss, including unclear responsibilities, inconvenient workspace design, or excessive documentation time.
Capacity also includes information flow. Confirm that patient identifiers remain linked across registers, instruments, worksheets, and reports. Check who reviews abnormal findings, who authorizes results, how urgent results are communicated, and how corrected reports are recorded. A technically accurate result can still fail its public health purpose if it is delayed or cannot be traced.
Interpret Gaps And Prioritize Risk
Classify findings according to their effect on patient safety, staff safety, result validity, continuity of service, and regulatory or program requirements. A missing backup printer may be inconvenient, while inadequate biosafety controls or unverified assay performance may make implementation unacceptable. This distinction helps managers direct limited resources to the most consequential problems.
Separate prerequisites from development actions. Prerequisites might include validated procedures, competent personnel, acceptable facility conditions, reliable specimen transport, functioning quality control, and a response plan for invalid results. Development actions could include automation, expanded reporting dashboards, additional storage, or gradual extension to more referring sites.
Estimate the resources needed to close each gap. Include construction or workflow changes, training time, maintenance, calibration, external quality assessment, information technology, waste management, and recurrent consumables. A simple budget that includes only the analyzer and cartridges will understate the true cost of service delivery.
Document evidence, responsible persons, deadlines, and verification methods in an action register. Each action should have a measurable completion point, such as “three staff members pass competency assessment” or “three months of temperature records meet the defined range.” Reassess high-risk findings before approval rather than treating a planned action as completed readiness.
Plan A Controlled Introduction
A staged rollout reduces operational risk. Start with a defined number of specimens or referral sites, monitor performance closely, and expand only when the laboratory meets agreed indicators. Early monitoring should include invalid and error rates, specimen rejection, turnaround time, stock availability, equipment downtime, EQA performance, corrected reports, and user feedback.
Use the assessment findings to create a practical implementation package:
- Approve a written scope, testing algorithm, and eligibility criteria for the initial service.
- Complete staff training, competency assessment, safety preparation, and supervised testing.
- Verify equipment, methods, reagents, information systems, and result-reporting procedures before routine use.
- Establish indicators, review frequency, escalation routes, and responsibilities for corrective action.
- Schedule a post-launch assessment after the first defined period and revise the rollout plan using documented evidence.
Communication with clinicians, collection sites, transport providers, and program managers should begin before the first test is run. Explain specimen requirements, rejection reasons, expected turnaround times, urgent result pathways, and procedures for repeat collection. Clear communication reduces avoidable workload and helps external users support the new service.
Approval should be based on demonstrated readiness, not enthusiasm for the technology or delivery of the equipment. If essential gaps remain, the laboratory can delay the launch, narrow the scope, or use a referral arrangement while improvements are completed. This protects patients and staff while preserving a realistic path toward expanded diagnostic capacity.
A structured assessment turns test expansion into a managed quality improvement activity. Use the findings to authorize a safe scope, assign resources, and monitor performance from the first day of service. Begin with the laboratory’s actual workflow and evidence, then build the new TB testing capability around reliable systems rather than around the instrument alone.